Robert Hood/Fred Hutch News ServiceDevelopment of more effective TB drugs and vaccines is a pressing, unmet medical need.
A study is set to find out whether Bacillus Calmette-Guérin (BCG) vaccine — made of comparatively harmless microbial cousins to human TB — might safely work as a stand-in for real TB germs in future clinical trials to assess new drugs and better vaccines to stop the disease.
Read the full story at Fred Hutchinson Cancer Center.
For more TB news, check out the latest edition of the TB Online Weekly Newsletter (#42, 18 December 2022).
Source : Fred Hutchinson Cancer Center
Related HIV and Co-Infections News
-
The potential of new TB vaccines offers hope at the Union Conference in a year of crisis
-
[Press release] WHO releases guidance on evidence generation on new regimens for TB preventive treatment
-
[Press release] TAG: New report urges action to ensure sustainable, affordable supply of key vaccine adjuvants for global health use
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.